Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Retained Earnings (2020 - 2025)

GeneDx Holdings (WGS) has disclosed Retained Earnings for 6 consecutive years, with -$1.4 billion as the latest value for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 1.55% to -$1.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.4 billion, a 1.55% decrease, with the full-year FY2025 number at -$1.4 billion, down 1.55% from a year prior.
  • Retained Earnings was -$1.4 billion for Q4 2025 at GeneDx Holdings, down from -$1.4 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $905000.0 in Q1 2025 to a low of -$1.4 billion in Q4 2025.
  • A 5-year average of -$783.4 million and a median of -$738.1 million in 2022 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: plummeted 940215.87% in 2021, then soared 211.0% in 2025.
  • GeneDx Holdings' Retained Earnings stood at -$575.4 million in 2021, then crashed by 41.75% to -$815.7 million in 2022, then skyrocketed by 100.05% to $425000.0 in 2023, then plummeted by 318329.18% to -$1.4 billion in 2024, then fell by 1.55% to -$1.4 billion in 2025.
  • Per Business Quant, the three most recent readings for WGS's Retained Earnings are -$1.4 billion (Q4 2025), -$1.4 billion (Q3 2025), and -$1.3 billion (Q2 2025).